Understand the source comparison
Peptides Help with Sleep Quality: Clinical vs Anecdotal Comparison
| Peptide | Mechanism of Action | Clinical Trial Evidence | Sleep Onset Latency Improvement | Slow-Wave Sleep Duration Increase | Typical Dosing Protocol | Professional Assessment ||—|—|—|—|—|—|| DSIP (Delta Sleep-Inducing Peptide) | Increases GABA-A receptor
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- | Peptide | Mechanism of Action | Clinical Trial Evidence | Sleep Onset Latency Improvement | Slow-Wave Sleep Duration Increase | Typical Dosing Protocol | Professional Assessment ||—|—|—|—|—|—|| DSIP (Delta Sleep-Inducing Peptide) | Increases GABA-A receptor density in VLPO, reduces cortisol secretion, modulates melatonin release | 14 controlled trials reviewed in Peptides (2021) meta-analysis | Mean reduction: 18 minutes | Mean increase: 52 minutes | 100–300 mcg subcutaneous injection 30–60 minutes before bed, 5–7 nights per week | Strongest clinical evidence for sleep onset and architecture improvement. Well-tolerated with minimal side effects || Epithalon (Epitalon) | Upregulates AANAT enzyme in pineal gland, increases endogenous melatonin synthesis, restores circadian amplitude | Multiple trials at St. Petersburg Institute of Bioregulation; 27% increase in melatonin output in adults >50 | Moderate. 12–15 minutes in older adults | Moderate. 30–40 minutes in participants with age-re